Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial (Q46638510)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 September 2013

Language	Label	Description	Also known as
English	Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial	scientific article published on 20 September 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

author name string

A Campanati

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

K Giuliodori

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

E Martina

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

A Giuliano

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

G Ganzetti

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

A Offidani

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

publication date

20 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

121

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

21-26

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Xeomin: an innovative new botulinum toxin type A.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Xeomin is free from complexing proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Focal hyperhidrosis: diagnosis and management

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Primary focal hyperhidrosis: disease characteristics and functional impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Recommendations for performing and evaluating the results of the minor test according to a sweating intensity visual scale.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Recognition, diagnosis, and treatment of primary focal hyperhidrosis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Sweat testing to evaluate autonomic function

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

The protein load of therapeutic botulinum toxins

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Treatment of idiopathic palmar hyperhidrosis with botulinum toxin. Report of 23 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1074-1

21 January 2018

Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An epidemiological study of hyperhidrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of grip strength: validity and reliability of the sphygmomanometer and jamar grip dynamometer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biology of sweat glands and their disorders. II. Disorders of sweat gland function

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxins 99, new information about the botulinum neurotoxins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparing Botox and Xeomin for axillar hyperhidrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary focal hyperhidrosis: scope of the problem.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosing, administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Spasticity Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24052109

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00702-013-1074-1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/24052109

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46638510&oldid=2207994936"